ema prac semaglutide naion label update 2025 Novo Nordisk's obesity-drug business has exploded in just a few years. Between 2021 and 2025, the company's sales in this segment jumped roughly tenfold: from $1.3 billion to $12.4 billion, driven largely Ozempic Blindness Lawsuit [2026 Guide]
Pay in 4 interest-free payments of $6.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
![ema prac semaglutide naion label update 2025 Novo Nordisk's obesity-drug business has exploded in just a few years. Between 2021 and 2025, the company's sales in this segment jumped roughly tenfold: from $1.3 billion to $12.4 billion, driven largely Ozempic Blindness Lawsuit [2026 Guide]](https://trulaw.com/wp-content/uploads/2025/11/The-Medical-Science-Behind-NAION.webp)
![ema prac semaglutide naion label update 2025 Novo Nordisk's obesity-drug business has exploded in just a few years. Between 2021 and 2025, the company's sales in this segment jumped roughly tenfold: from $1.3 billion to $12.4 billion, driven largely Ozempic Blindness Lawsuit [2026 Guide]](https://mediamice.com/wp-content/uploads/2026/02/image-1024x452.png)
![ema prac semaglutide naion label update 2025 Novo Nordisk's obesity-drug business has exploded in just a few years. Between 2021 and 2025, the company's sales in this segment jumped roughly tenfold: from $1.3 billion to $12.4 billion, driven largely Ozempic Blindness Lawsuit [2026 Guide]](https://www.ema.europa.eu/sites/default/files/styles/ema_smp_twitter/public/2026-06/2026_PRAC_WEB_AD64096328.png.webp?itok=HWRb0Fkh)























